The future of medical technology in cancer looks promising with the development of nanotechnology, bioprinting, and advanced biosensors. Nanotechnology aims to deliver drugs directly to cancer cells, reducing side effects and improving efficacy. Bioprinting holds potential for creating personalized tissue models for testing treatments, while advanced biosensors can provide real-time monitoring of cancer biomarkers.
